| Primary |
| Product Used For Unknown Indication |
40.8% |
| Hereditary Angioedema |
40.4% |
| Asthma |
2.5% |
| Nausea |
1.5% |
| Pain |
1.5% |
| Abdominal Pain |
1.4% |
| Anxiety |
1.4% |
| Hypersensitivity |
1.4% |
| Hypertension |
1.1% |
| Back Pain |
1.0% |
| Depression |
1.0% |
| Wheezing |
1.0% |
| Diabetes Mellitus |
0.8% |
| Migraine |
0.8% |
| Muscle Spasms |
0.8% |
| Sleep Disorder |
0.7% |
| Abdominal Distension |
0.6% |
| Premedication |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.4% |
| Contraception |
0.4% |
|
| Hypersensitivity |
12.9% |
| Hereditary Angioedema |
11.3% |
| Anaphylactic Reaction |
6.5% |
| Off Label Use |
6.5% |
| Vomiting |
6.5% |
| Drug Ineffective For Unapproved Indication |
4.8% |
| Injection Site Reaction |
4.8% |
| Malaise |
4.8% |
| Syncope |
4.8% |
| Urticaria |
4.8% |
| Anaphylactic Shock |
3.2% |
| Blood Pressure Decreased |
3.2% |
| Death |
3.2% |
| Dehydration |
3.2% |
| Drug Effect Delayed |
3.2% |
| Large Cell Lung Cancer Metastatic |
3.2% |
| Neutrophil Count Increased |
3.2% |
| Oxygen Saturation Abnormal |
3.2% |
| Pancreatitis |
3.2% |
| Pneumonia |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
42.0% |
| Hereditary Angioedema |
36.9% |
| Abdominal Pain |
3.7% |
| Abdominal Distension |
2.2% |
| Asthma |
1.6% |
| Hypersensitivity |
1.5% |
| Anxiety |
1.4% |
| Depression |
1.4% |
| Nausea |
1.4% |
| Pain |
1.4% |
| Back Pain |
1.2% |
| Migraine |
1.0% |
| Diabetes Mellitus |
0.9% |
| Hypertension |
0.7% |
| Polycystic Ovaries |
0.5% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Sleep Disorder |
0.4% |
| Type 1 Diabetes Mellitus |
0.4% |
| Wheezing |
0.4% |
| Attention Deficit/hyperactivity Disorder |
0.3% |
|
| Hereditary Angioedema |
13.1% |
| Visual Impairment |
10.1% |
| Syncope |
7.1% |
| Vomiting |
7.1% |
| Hypersensitivity |
6.1% |
| Drug Ineffective For Unapproved Indication |
5.1% |
| Thyroid Disorder |
5.1% |
| Dehydration |
4.0% |
| Drug Effect Delayed |
4.0% |
| Drug Ineffective |
4.0% |
| Off Label Use |
4.0% |
| Pancreatitis |
4.0% |
| Sepsis |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Anaphylactic Reaction |
3.0% |
| Angioedema |
3.0% |
| Drug Interaction |
3.0% |
| Erythema |
3.0% |
| Hypoxia |
3.0% |
| Lobar Pneumonia |
3.0% |
|
| Concomitant |
| Hereditary Angioedema |
15.7% |
| Pain |
11.1% |
| Constipation |
10.5% |
| Asthma |
9.4% |
| Product Used For Unknown Indication |
8.7% |
| Insomnia |
5.6% |
| Nausea |
5.2% |
| Pulmonary Embolism |
3.5% |
| Hypertension |
3.1% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Convulsion |
2.4% |
| Deep Vein Thrombosis |
2.4% |
| Disbacteriosis |
2.4% |
| Faeces Hard |
2.4% |
| Hyperlipidaemia |
2.4% |
| Hypersensitivity |
2.4% |
| Migraine |
2.4% |
| Muscle Relaxant Therapy |
2.4% |
| Osteoporosis |
2.4% |
| Seasonal Allergy |
2.4% |
|
| Hereditary Angioedema |
28.6% |
| Pancreatitis |
9.5% |
| Therapy Regimen Changed |
9.5% |
| Abdominal Mass |
4.8% |
| Anaemia |
4.8% |
| Arthralgia |
4.8% |
| Back Pain |
4.8% |
| Menstruation Irregular |
4.8% |
| Nasopharyngitis |
4.8% |
| Pain |
4.8% |
| Syncope |
4.8% |
| Therapy Change |
4.8% |
| Urinary Tract Infection |
4.8% |
| Vocal Cord Disorder |
4.8% |
|
